These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11377437

  • 21. Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I.
    Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, Heuser IJ.
    Biol Psychiatry; 1995 Dec 15; 38(12):797-802. PubMed ID: 8750037
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prediction of depressive relapse in remitted bipolar patients using corticotrophin-releasing hormone challenge test.
    Vieta E, Gasto C, Martinez de Osaba MJ, Nieto E, Canto TJ, Otero A, Vallejo J.
    Acta Psychiatr Scand; 1997 Mar 15; 95(3):205-11. PubMed ID: 9111853
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr 15; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 28. Hormonal responsiveness in the Trier Social Stress Test and the dexamethasone-corticotropin releasing hormone test in healthy individuals.
    Petrowski K, Herhaus B, Conrad R, Bornstein SR.
    Psych J; 2021 Apr 15; 10(2):305-317. PubMed ID: 33511783
    [Abstract] [Full Text] [Related]

  • 29. Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients.
    Vieta E, Martínez-De-Osaba MJ, Colom F, Martínez-Arán A, Benabarre A, Gastó C.
    Psychol Med; 1999 Jul 15; 29(4):971-8. PubMed ID: 10473324
    [Abstract] [Full Text] [Related]

  • 30. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls.
    Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH.
    Psychoneuroendocrinology; 2009 Sep 15; 34(8):1208-13. PubMed ID: 19375869
    [Abstract] [Full Text] [Related]

  • 31. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P.
    Psychopharmacology (Berl); 2005 Oct 15; 181(4):751-60. PubMed ID: 15988572
    [Abstract] [Full Text] [Related]

  • 32. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.
    Neuropsychobiology; 2007 Oct 15; 55(1):21-7. PubMed ID: 17556849
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
    Neuropsychopharmacology; 2006 Jan 15; 31(1):212-20. PubMed ID: 16123748
    [Abstract] [Full Text] [Related]

  • 36. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
    Wirtz PH, Siegrist J, Schuhmacher A, Hoefels S, Maier W, Zobel AW.
    Psychoneuroendocrinology; 2010 May 15; 35(4):536-43. PubMed ID: 19818562
    [Abstract] [Full Text] [Related]

  • 37. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
    Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
    [Abstract] [Full Text] [Related]

  • 38. Relationships of DEX/CRH and GHRH test results to the outcome of depression--preliminary results suggest the GHRH test may predict relapse after discharge.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    J Psychiatr Res; 2008 Apr 15; 42(5):356-64. PubMed ID: 17412362
    [Abstract] [Full Text] [Related]

  • 39. Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients.
    Watson S, Gallagher P, Smith MS, Young AH, Ferrier IN.
    Psychoneuroendocrinology; 2007 Jun 15; 32(5):464-9. PubMed ID: 17442500
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.